Insider Transactions in Q2 2023 at Aridis Pharmaceuticals, Inc. (ARDS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2023
|
Eric Patzer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+1.65%
|
-
|
|
Jun 05
2023
|
Hasan Jafri Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+39.84%
|
-
|
|
Jun 05
2023
|
Susan Richards Windham Bannister Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 05
2023
|
Vu Truong CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+1.95%
|
-
|
|
Jun 05
2023
|
John F Hamilton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 05
2023
|
Fred Kurland CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|